МОСКВА, Россия, 24 декабря 2019 г. – GE Healthcare представила на российском рынке новую ангиографическую систему экспертного класса Optima IGS 330 (1). Благодаря универсальности функционала и компактности конструкции аппарат отвечает широкому кругу медицинских задач стационаров различного уровня: от катетеризационных лабораторий в составе больниц до первичных межмуниципальных сосудистых центров.
CHICAGO, IL – December 20, 2019 - GE Healthcare is issuing a voluntary field action for certain CARESCAPE Respiratory Modules and Airway Gas Options and their respective service exchange units and field replaceable units that are used with certain GE Healthcare monitors, anesthesia and respiratory devices. The company is taking this action after internally identifying approximately 800 products of which a small number may have had a soldering step omitted during the manufacturing process.
For media inquiries, please contact:
Jennifer Fox414-530-3027
[email protected]
business unit
【東京 2019年12月18日】 日本の医療課題の解決に取り組むヘルスケアカンパニー、GEヘルスケア・ジャパン株式会社（本社：東京都日野市、代表取締役社長兼CEO：多田荘一郎 以下、GEヘルスケア・ジャパン）と、ロシュ・ダイアグノスティックス株式会社（本社：東京都港区、代表取締役社長兼 CEO 小笠原 信、以下ロシュ・ダイアグノスティックス） は、業界初の試みである「Peer to Peer Coaching」（以下、ピアコーチング）を共同で企画し、2019年2月より半年以上の期間にわたって、両社から11名ずつ選抜された社員を対象に実施しました。 今回の実施から得られた数々の価値ある気付きを踏まえ、今年のみの開催に留まらず、来年以降も企業間での展開を予定しています。
business unit
MILWAUKEE, WI – December 16, 2019 - GE Healthcare has issued a voluntary field corrective action for all Giraffe Incubator, Giraffe OmniBed, Giraffe Incubator Carestation, and Giraffe OmniBed Carestation systems. As part of the action, hospitals are receiving materials that reinforce instructions provided in the user manuals for these systems. Hospitals can continue to use these systems by following these instructions.
For media inquiries, please contact:
Jennifer Fox414-530-3027
[email protected]
business unit
- New facility will help alleviate bottlenecks in manufacturing that impact preclinical research
December 16, 2019 - GE Healthcare (GEHC) Life Sciences and the University of Massachusetts Medical School (UMMS) have come together to establish a Large Scale Viral Vector Manufacturing Facility. The new facility will provide large quantities of high-quality recombinant adeno-associated virus (AAV) vectors for preclinical research. The facility will be housed on the University of Massachusetts Medical School’s Worcester campus.
business unit
Buc, France – December 2, 2019 – GE Healthcare and Affidea, the pan-European leader in advanced diagnostic imaging, outpatient and cancer care services, have signed a multi-year agreement to deploy imaging and digital technologies across the Affidea network.
GE Healthcare will install 200+ new equipment in Affidea’s network of centers across Europe. The deal includes the provision of 60 new MRIs, 50 ultrasound devices, 40 CT scanners and 30 X-rays machines in the next 3 years. It also includes a six-year service contract.
For media inquiries, please contact:
Melania PopielEastern Europe Communications Manager
GE Healthcare
+48 504 455 345
[email protected] Oana Dumitroiu
Head of Brand & Communication
Affidea
+40 738 674 320
[email protected]
business unit
- Software offers customized profile set-up, simplifies process validation, and minimizes variability in cell transduction via spinoculation
December 2, 2019 - GE Healthcare Life Sciences continues to build out its flexible solutions across the cell therapy workflow with the commercial availability of SpinOculation C-Pro Protocol Software. Part of the Sepax™ C-Pro Cell Processing System, the software closes and automates the cell transduction step.
business unit
• Emerging technologies and industry-adjacent collaborations to help deliver on promise of precision health, empowering clinicians and impacting patient care via additive, robotic and digital innovations
GE Healthcare
4144127062
[email protected]
For media inquiries, please contact:
Amanda GintoftGE Healthcare
4144127062
[email protected]